MC
Matthew Caufield HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
57
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
91.9%
Neutral
8.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Electronic Components
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $5 |
64%
downside
| 6 | +7.2% |
0
%
| 2 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $4 |
348%
upside
| 6 | -15% |
0
%
| 26 Feb ‘26 3 months ago |
|
|
|
Buy
Maintained
| $18 |
217%
upside
| 2 | +38% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Buy
Reiterated
| $44 |
135%
upside
| 4 | +40% |
0
%
| 10 Feb ‘26 4 months ago |
|
|
|
Buy
Reiterated
| $38 |
12%
upside
| 6 | +7.8% |
0
%
| 10 Feb ‘26 4 months ago |
|
|
|
Buy
Reiterated
| $6 |
539%
upside
| 4 | -16% |
0
%
| 6 Feb ‘26 4 months ago |
|
|
|
Neutral
Downgraded
| $5 |
15%
upside
| 4 | +19% |
0
%
| 17 Nov ‘25 7 months ago |
|
|
|
Buy
Maintained
| $56 |
134%
upside
| 7 | +21% |
0
%
| 12 Nov ‘25 7 months ago |
|
|
|
Buy
Maintained
| $26 |
143%
upside
| 3 | +65% |
0
%
| 31 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $88 |
42%
upside
| 2 | +32% |
0
%
| 20 Oct ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $12 |
113%
upside
| 4 | +11% |
0
%
| 15 Aug ‘25 10 months ago |
|
|
|
Neutral
Reiterated
| $16 |
3,132%
upside
| 2 | – |
–
| 14 Aug ‘25 10 months ago |
|
|
|
Buy
Maintained
| $56 |
745%
upside
| 4 | -8.6% |
0
%
| 1 Aug ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $8 |
104%
upside
| 2 | +205% |
0
%
| 27 Jun ‘25 11 months ago |
|